Adam Huskerson, MD
Sports Medicine · Stillwater, OKNPI 1659631448
Payments from drug & device makers
What this record shows
15 manufacturers reported payments, led by Pacira Pharmaceuticals Incorporated at 47.7% of the total. 2025 is the largest year on record at $975, more than ten times the $54 reported in 2019.
Across 35 payments — averaging $53.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pacira Pharmaceuticals Incorporated$896
- Stryker$205
- Johnson & Johnson$158
- Tenex Health Inc.$143
- Trice Medical, Inc.$123
- Bioventus LLC$72
- plus $281 from 9 others
What the payments were for
- Travel & lodging$75940%
- Food & beverage$1,12060%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pacira Pharmaceuticals Incorporated | 8 | $896 |
| Stryker | 4 | $205 |
| Johnson & Johnson(2 entities) | 5 | $158 |
| Tenex Health Inc. | 1 | $143 |
| Trice Medical, Inc. | 1 | $123 |
| Bioventus LLC | 4 | $72 |
| Medline Industries LP | 1 | $51 |
| Convatec Inc. | 2 | $48 |
| Pacira Therapeutics, Inc. | 2 | $36 |
| Orthofix Medical, Inc. | 1 | $30 |
| Kowa Pharmaceuticals America, Inc. | 2 | $29 |
| Baudax Bio Inc. | 1 | $25 |
| Acera Surgical, Inc. | 1 | $22 |
| Pylant Medical | 1 | $20 |
| P Bar Medical LLC | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Iovera$759
How this compares
$1,879 in reported general payments places this provider in the 60th percentile of 55 sports medicine providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine | 11 | $718 |
| Gabapentin | 17 | $231 |
| Methylprednisolone | 43 | $228 |
| Celecoxib | 11 | $85 |
| Meloxicam | 20 | $32 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Stillwater
- Antoine JabbourTulsa$55K
- John GlomsetNorman$47K
- Chad HansonTulsa$40K
- Michael MaxtedOklahoma City$23K
- Jaya ShanmugamBartlesville$18K
- Jason GriffinTulsa$17K
- Gwendolyn EmersonTulsa$13K
- Andrew EbertTulsa$11K
- Kevin DukesTulsa$8K
- George GhataOklahoma City$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.